Stryker (NYSE:SYK) Reaches New 52-Week High Following Analyst Upgrade
Stryker (NYSE:SYK) Reaches New 52-Week High Following Analyst Upgrade
Stryker Co. (NYSE:SYK – Get Rating)'s stock price reached a new 52-week high during trading on Thursday after Barclays raised their price target on the stock from $265.00 to $283.00. Barclays currently has an overweight rating on the stock. Stryker traded as high as $281.45 and last traded at $280.70, with a volume of 24622 shares traded. The stock had previously closed at $278.95.
在巴克莱将该股目标价从265.00美元上调至283.00美元后,Stryker Co.(纽约证券交易所代码:SYK-GET Rating)的股价在周四的交易中创下52周新高。巴克莱目前对该股的评级为增持。Stryker的交易价格最高为281.45美元,最新交易价格为280.70美元,成交量为24622股。该股此前收盘时为278.95美元。
A number of other research analysts have also recently commented on SYK. TheStreet upgraded Stryker from a "c+" rating to a "b" rating in a research note on Tuesday, November 22nd. Truist Financial upped their price objective on Stryker from $257.00 to $275.00 and gave the stock a "hold" rating in a research report on Wednesday. Royal Bank of Canada upped their price objective on Stryker from $284.00 to $288.00 and gave the stock an "outperform" rating in a research report on Wednesday. Cowen upped their price objective on Stryker from $233.00 to $283.00 in a research report on Wednesday, December 14th. Finally, Canaccord Genuity Group lowered Stryker from a "buy" rating to a "hold" rating and cut their price objective for the stock from $225.00 to $220.00 in a research report on Tuesday, November 1st. Seven equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Stryker has a consensus rating of "Moderate Buy" and a consensus target price of $271.32.
其他一些研究分析师最近也对SYK发表了评论。华尔街在11月22日星期二的一份研究报告中将Stryker的评级从C+上调至B。Truist Financial在周三的一份研究报告中将Stryker的目标价从257.00美元上调至275.00美元,并给予该股“持有”评级。周三,加拿大皇家银行在一份研究报告中将史赛克的目标价从284.00美元上调至288.00美元,并给予该股“跑赢大盘”的评级。考恩在12月14日星期三的一份研究报告中将其对Stryker的目标价从233.00美元上调至283.00美元。最后,在11月1日周二的一份研究报告中,Canaccel Genuity Group将Stryker的评级从“买入”下调至“持有”,并将其股票目标价从225.00美元下调至220.00美元。7名股票研究分析师对该股的评级为持有,14名分析师对该公司股票的评级为买入。根据MarketBeat的数据,Stryker的共识评级为“适度买入”,共识目标价为271.32美元。
Insiders Place Their Bets
内部人士下注
In other Stryker news, CEO Kevin Lobo sold 67,232 shares of the firm's stock in a transaction dated Friday, December 2nd. The stock was sold at an average price of $239.68, for a total transaction of $16,114,165.76. Following the transaction, the chief executive officer now owns 80,770 shares of the company's stock, valued at $19,358,953.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Stryker news, VP M Kathryn Fink sold 6,571 shares of the firm's stock in a transaction dated Wednesday, January 11th. The stock was sold at an average price of $257.69, for a total transaction of $1,693,280.99. Following the transaction, the vice president now owns 9,264 shares of the company's stock, valued at $2,387,240.16. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin Lobo sold 67,232 shares of the stock in a transaction dated Friday, December 2nd. The stock was sold at an average price of $239.68, for a total transaction of $16,114,165.76. Following the sale, the chief executive officer now owns 80,770 shares of the company's stock, valued at approximately $19,358,953.60. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 79,139 shares of company stock valued at $19,150,115. 6.70% of the stock is currently owned by insiders.
在Stryker的其他消息中,首席执行官凯文·洛博在12月2日星期五的一笔交易中出售了67,232股公司股票。该股以239.68美元的平均价格出售,总成交金额为16,114,165.76美元。交易完成后,这位首席执行官现在持有该公司80,770股股票,价值19,358,953.60美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。在Stryker的其他新闻中,副总裁M Kathryn Fink在1月11日星期三的一笔交易中出售了6571股该公司的股票。股票以257.69美元的平均价格出售,总成交金额为1,693,280.99美元。交易完成后,副总经理总裁现在持有该公司9264股股票,价值2387,240.16美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。此外,首席执行官凯文·洛博在12月2日星期五的交易中出售了67,232股该公司股票。该股以239.68美元的平均价格出售,总成交金额为16,114,165.76美元。出售后,首席执行官现在拥有80,770股公司股票,价值约19,358,953.60美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士出售了79,139股公司股票,价值19,150,115美元。该公司6.70%的股份目前由内部人士持有。
Institutional Investors Weigh In On Stryker
机构投资者看好Stryker
Stryker Trading Up 1.3 %
Stryker股价上涨1.3%
The company has a market cap of $106.90 billion, a price-to-earnings ratio of 45.35, a PEG ratio of 2.83 and a beta of 0.93. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 2.04. The business's 50 day moving average price is $247.78 and its 200-day moving average price is $226.11.
该公司市值为1,069亿美元,市盈率为45.35倍,市盈率为2.83倍,贝塔系数为0.93。该公司的负债权益比率为0.77,速动比率为1.19,流动比率为2.04。该业务的50日移动均线价位为247.78美元,200日移动均线价位为226.11美元。
Stryker (NYSE:SYK – Get Rating) last announced its earnings results on Tuesday, January 31st. The medical technology company reported $3.00 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.84 by $0.16. The business had revenue of $5.20 billion during the quarter, compared to analysts' expectations of $4.97 billion. Stryker had a net margin of 12.78% and a return on equity of 22.70%. The firm's revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the company posted $2.71 EPS. On average, research analysts forecast that Stryker Co. will post 9.83 EPS for the current year.
Stryker(纽约证券交易所代码:SYK-GET Rating)最近一次公布收益结果是在1月31日星期二。这家医疗技术公司公布,该季度每股收益(EPS)为3.00美元,超出分析师普遍预期的2.84美元,超出0.16美元。该业务当季营收为52亿美元,高于分析师预期的49.7亿美元。Stryker的净利润率为12.78%,股本回报率为22.70%。该公司当季营收较上年同期增长10.7%。去年同期,该公司公布的每股收益为2.71美元。研究分析师平均预测,Stryker Co.本年度每股收益将达到9.83欧元。
Stryker Increases Dividend
Stryker增加股息
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 31st. Investors of record on Friday, December 30th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, December 29th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.06%. This is a boost from Stryker's previous quarterly dividend of $0.70. Stryker's dividend payout ratio (DPR) is 48.62%.
该公司最近还宣布了季度股息,股息于1月31日(星期二)支付。12月30日(星期五)登记在册的投资者获得了每股0.75美元的股息。除息日期是12月29日星期四。这意味着年化股息为3.00美元,股息收益率为1.06%。这比Stryker之前0.70美元的季度股息有所提振。Stryker的派息比率(DPR)为48.62%。
About Stryker
关于史崔克
(Get Rating)
(获取评级)
Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries.
Stryker Corp.是一家医疗技术公司。它通过以下部门开展业务:整形外科和脊柱以及医学外科和神经技术。骨科和脊柱部门提供用于全关节置换的植入物,如髋关节、膝盖和肩部,以及创伤和四肢手术。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Stryker (SYK)
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
- 免费获取StockNews.com关于Stryker的研究报告(SYK)
- 凯西·伍兹的方舟创新ETF将在2023年反弹?
- 马伦汽车公司股票因利好消息而上涨
- 哈雷-戴维森公司的股票,是时候买入了吗?
- Meta平台的底部已经到了,波动性还没有结束
- 阿拉斯加航空公司近期收益分析
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
接受Stryker Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Stryker和相关公司的最新新闻和分析师评级的每日简要摘要。